Calls for Medication Checks Strengthen After Infant’s Death

The tragic death of Bellamere Arwyn Duncan, a two-month-old infant, has sparked renewed calls for legislative changes concerning medication dispensation in New Zealand. Following her death at Starship Hospital on July 19, 2023, health professionals are advocating for mandatory checks requiring two healthcare workers to verify medications before they are dispensed.

According to reports, the infant received an adult dosage of phosphate from a Manawatū pharmacy. A preliminary opinion from a coroner suggests that the cause of death was phosphate toxicity, prompting serious concerns regarding medication safety in neonatal care settings.

Dr. Harlene H. S. Ma, a clinical director at a Neonatal Intensive Care Unit, expressed her support for the proposed law change. She emphasized that such measures could prevent similar tragedies in the future. “We must ensure that no other family endures the heartache that Bellamere’s family has faced,” Dr. Ma stated.

The Pharmaceutical Society of New Zealand has also acknowledged the need for reform. A member of the national executive noted that while changes in the law are essential, the pharmacy workforce requires better resources to implement these safety checks effectively. He described the current state of the New Zealand pharmacy workforce as “in crisis,” suggesting that inadequate staffing levels may contribute to medication errors.

Health experts have pointed out that the issue of medication safety is critical, particularly in sensitive environments such as neonatal care. The need for rigorous checks is underscored by the vulnerabilities of infants, who may react severely to dosages that are inappropriate for their age and size.

As the investigation continues, the call for improved medication verification procedures has gained traction. Advocates for change hope that this incident will lead to legislative action that enhances patient safety across healthcare settings in New Zealand.

The tragic circumstances surrounding Bellamere’s death serve as a poignant reminder of the importance of vigilance in medication administration. Stakeholders are urged to engage in discussions that prioritize the safety and well-being of patients, particularly the most vulnerable.